Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Analysis of advanced lung cancer patients diagnosed following emergency admission Source: Eur Respir J 2015; 45: 1098-1107 Year: 2015
Clubbing regression in surgically treated lung cancer patients. A study of 34 cases Source: Eur Respir J 2002; 20: Suppl. 38, 436s Year: 2002
Videothoracoscopic lung biopsy (VATS-LB) in the diagnosis of diffuse interstitial lung disease (DILD) and evaluation of an outpatient surgical approach. A prospective multicentric study Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005
Pirfenidone in unclassifiable ILD (uILD): subgroup analysis of patients with/without a surgical lung biopsy (SLB) Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020
Dealys in the diagnosis and treatment of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004
Regression of clubing in surgically treated patients with lung cancer. A study of 34 cases Source: Eur Respir J 2004; 24: Suppl. 48, 671s Year: 2004
Does surgical lung biopsy change the diagnosis and treatment in interstitial lung diseases? Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010
In patients with treatment-sensitive cancers, does systemic anti-cancer therapy increase the chance of malignant pleural effusion control? Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020
Evaluation of intrapericardial cisplatin (CIS) administration in cases with recurrent malignant pericardial effusion (MPE) in pts with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 63s Year: 2003
Typical pulmonary carcinoid tumors: presentation, diagnosis and outcome in 24 cases Source: Eur Respir J 2004; 24: Suppl. 48, 532s Year: 2004
Features affecting stages of patients with lung cancer at diagnosis Source: Eur Respir J 2005; 26: Suppl. 49, 536s Year: 2005
Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008
Some characteristics of empyema in lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 74s Year: 2005
Factors affecting the duration from diagnosis to treatment in patients with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007
Lobectomy at patients with lung cancer and a chronic obstructive pulmonary disease as analogue of lung volume reduction surgery in COPD patients: To do or not to do? Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013